ADIA Nutrition Inc. Provides Shareholder Update on Acquisition of Biolete Inc. and Financial Position
ADIA Nutrition Inc. (OTC Pink: ADIA) has provided a shareholder update on its recent acquisition of Biolete Inc. and its financial position. The acquisition includes Biolete's , trademark, customer base, and coffee inventory. ADIA aims to leverage these assets to drive revenue and enhance shareholder value, particularly in the growing high-protein and mushroom coffee markets.
Key financial points:
- ADIA has no debt for deferred salaries, convertible notes, or toxic debt
- The company's only debt is draws from a 6% Annum $500,000 line of credit provided by CEO Larry Powalisz
- No additional funding beyond the line of credit is required for current operations
The company is well-positioned to execute its business plan, including opening its first clinic for aHSCT for MS and supporting its supplement division.
ADIA Nutrition Inc. (OTC Pink: ADIA) ha fornito un aggiornamento agli azionisti riguardo alla sua recente acquisizione di Biolete Inc. e alla sua posizione finanziaria. L'acquisizione comprende il marchio di Biolete, il portafoglio clienti e l'inventario di caffè. ADIA intende valorizzare questi attivi per generare ricavi e accrescere il valore per gli azionisti, in particolare nei mercati in crescita del caffè ad alto contenuto proteico e a base di funghi.
Punti finanziari chiave:
- ADIA non ha debiti per salari differiti, note convertibili o debito tossico
- Il debito dell'azienda è costituito esclusivamente da prelievi da una linea di credito di $500.000 al 6% annuo fornita dal CEO Larry Powalisz
- Non è necessario ulteriore finanziamento oltre alla linea di credito per le operazioni attuali
La società è ben posizionata per attuare il suo piano aziendale, incluso l'apertura della sua prima clinica per un aHSCT per la SM e il supporto della sua divisione integratori.
ADIA Nutrition Inc. (OTC Pink: ADIA) ha proporcionado una actualización a los accionistas sobre su reciente adquisición de Biolete Inc. y su posición financiera. La adquisición incluye la marca de Biolete, su base de clientes y el inventario de café. ADIA busca aprovechar estos activos para impulsar los ingresos y aumentar el valor para los accionistas, especialmente en los crecientes mercados de café alto en proteínas y de café con champiñones.
Puntos financieros clave:
- ADIA no tiene deudas por salarios diferidos, notas convertibles o deudas tóxicas
- La única deuda de la compañía son los retiros de una línea de crédito de $500,000 al 6% anual proporcionada por el CEO Larry Powalisz
- No se requiere financiamiento adicional más allá de la línea de crédito para las operaciones actuales
La empresa está bien posicionada para ejecutar su plan de negocios, incluyendo la apertura de su primera clínica para aHSCT para EM y el apoyo a su división de suplementos.
ADIA Nutrition Inc. (OTC Pink: ADIA)는 Biolete Inc.의 최근 인수 및 재무 상태에 대한 주주 업데이트를 제공했습니다. 인수에는 Biolete의 상표, 고객 기반 및 커피 재고가 포함됩니다. ADIA는 이러한 자산을 활용하여 수익을 창출하고 주주 가치를 향상시키는 것을 목표로 하며, 특히 고단백 및 버섯 커피 시장의 성장에 주목하고 있습니다.
주요 재무 포인트:
- ADIA는 연체 급여, 전환사채 또는 유독성 부채가 없습니다
- 회사의 유일한 부채는 CEO Larry Powalisz가 제공한 연 6%의 $500,000 신용 한도에서 인출한 것입니다
- 현재 운영을 위해 신용 한도 이상의 추가 자금이 필요하지 않습니다
회사는 MS에 대한 aHSCT를 위한 첫 번째 클리닉 개설과 보충제 부문 지원을 포함하여 사업 계획을 실행할 준비가 잘 되어 있습니다.
ADIA Nutrition Inc. (OTC Pink: ADIA) a fourni une mise à jour aux actionnaires concernant son acquisition récente de Biolete Inc. et sa situation financière. L'acquisition comprend la marque de Biolete, sa clientèle et son inventaire de café. ADIA vise à exploiter ces actifs pour générer des revenus et accroître la valeur pour les actionnaires, en particulier sur les marchés en pleine croissance du café riche en protéines et à base de champignons.
Points financiers clés :
- ADIA n'a aucune dette pour des salaires différés, des billets convertibles ou des dettes toxiques
- La seule dette de l'entreprise provient de retraits sur une ligne de crédit de 500 000 $ à 6 % par an fournie par le PDG Larry Powalisz
- Aucun financement supplémentaire au-delà de la ligne de crédit n'est requis pour les opérations actuelles
L'entreprise est bien positionnée pour exécuter son plan d'affaires, y compris l'ouverture de sa première clinique pour aHSCT pour la SEP et le soutien de sa division de suppléments.
ADIA Nutrition Inc. (OTC Pink: ADIA) hat ein Update für die Aktionäre zu seiner aktuellen Übernahme von Biolete Inc. und seiner finanziellen Lage bereitgestellt. Die Übernahme umfasst das Markenzeichen von Biolete, den Kundenstamm und den Kaffeebestand. ADIA plant, diese Vermögenswerte zu nutzen, um den Umsatz zu steigern und den Aktienwert zu erhöhen, insbesondere in den wachsenden Märkten für proteinreiche und Pilzkaffees.
Wichtige Finanzpunkte:
- ADIA hat keine Schulden für aufgeschobene Gehälter, wandelbare Anleihen oder toxische Schulden
- Die einzige Schuld des Unternehmens sind Abhebungen von einer 500.000 $ Kreditlinie zu 6% p.a, die von CEO Larry Powalisz bereitgestellt wird
- Für die aktuellen Operationen ist keine zusätzliche Finanzierung über die Kreditlinie erforderlich
Das Unternehmen ist gut positioniert, um seinen Geschäftsplan auszuführen, einschließlich der Eröffnung seiner ersten Klinik für aHSCT für MS und der Unterstützung seiner Ergänzungsabteilung.
- Acquisition of Biolete Inc. includes revenue-generating customer base and inventory
- Strong market potential: high-protein coffee market projected to reach $2.64 billion by 2029
- Mushroom coffee market expected to grow to $4.12 billion by 2030
- $500,000 line of credit at 6% interest rate from CEO to fund operations
- No toxic debt or need for additional funding beyond the line of credit
- None.
Winter Park, Florida--(Newsfile Corp. - August 27, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA) is pleased to provide a shareholder update regarding its recent acquisition of Biolete Inc. and its financial position.
As part of the acquisition, ADIA Nutrition has acquired not only the Biolete corporation and its trademark but also its current customer base, which has been generating revenue for Biolete. Additionally, ADIA Nutrition has taken possession of the Biolete Coffee inventory, from both of Biolete's former warehouses.
The global high-protein coffee market was valued at approximately USD 1.56 billion in 2021 and is projected to reach USD 2.64 billion by 2029. Similarly, the global mushroom coffee market was valued at USD 2.71 billion in 2022 and is expected to grow at a CAGR of
The acquisition of Biolete's customer base and inventory strengthens ADIA Nutrition's position in the market and provides a solid foundation for growth.
This includes ADIA's offering of Biolete coffee across various platforms including Amazon. The company is confident in its ability to leverage these assets to drive revenue and enhance shareholder value.
ADIA Nutrition would also like to clarify that ADIA has no debt for deferred salaries, convertible notes, or any other toxic debt. ADIA's only debt is and will be draws from its
ADIA does not require additional funding beyond the
"We are excited about the acquisition of Biolete and the opportunities it presents for ADIA Nutrition," said Larry Powalisz, CEO of ADIA Nutrition Inc. "The acquisition of the customer base and inventory, along with the line of credit provided by myself, positions us for success in the coming months. We are confident in our ability to expedite our business plan and not only create value for our shareholders, but also help MS Patients faster than originally anticipated."
For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adia-med.com
Website: www.biolete.com
Website: www.cementfactory.com
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/221114
FAQ
What did ADIA Nutrition Inc. (ADIA) acquire from Biolete Inc.?
How is ADIA Nutrition Inc. (ADIA) financing its operations?
What are ADIA Nutrition Inc.'s (ADIA) plans for the acquired Biolete assets?
What is the market outlook for high-protein and mushroom coffee, which ADIA Nutrition Inc. (ADIA) is now involved in?
